Growing consumer demand for transparency in the personal care industry and scientific advancements facilitating more ethical practices are putting pressure on regulators to enforce stricter policing on brands and formulators. Animal cruelty in the industry has long been of public concern, and as New Approach Methodologies (NAMs) gain credit, in vivo assessments are becoming less necessary to determine a product’s or ingredients’ safety.

The US FDA recently announced a plan to replace animal testing in the developmental phases of some antibodies and drugs with more human-relevant alternatives.

While supporting the FDA’s decision, the Personal Care Products Council (PCPC) argues that these human-relevant testing methods have long existed and that the plan to phase out animal testing methods should be applied to more industries — such as personal care — not just antibody and drug testing.

Personal Care Insights speaks with the PCPC about how NAMs have the potential to trump animal testing and the obstacles keeping it from becoming the industry standard.

Read more: click here